CE marked MACS® IVD Antibodies by Miltenyi Biotec – Compliant with IVDD and produced according to ISO 13485

BERGISCH GLADBACH, 19. September 2016 – Miltenyi Biotec has expanded its assortment of antibodies with a series of CE marked in vitro-diagnostic medical devices – MACS® IVD Antibodies. They can be used in both clinical flow cytometry and in the quality control of cellular products for translational research. The renowned biotech company from Bergisch Gladbach... Read more

GE to invest €150 million in biopharmaceutical manufacturing campus in Cork, Ireland, and establish advanced manufacturing training centre at NIBRT

CORK – 19 September, 2016 – Ireland’s Minister for Jobs, Enterprise and Innovation, Mary Mitchell O’Connor TD, today announced that GE (NYSE:GE) is to invest €150 million in a new biopharmaceutical manufacturing campus on Industrial Development Agency (IDA) Ireland’s strategic site at Loughbeg, Ringaskiddy, Co. Cork.  GE BioPark Cork, subject to contract and planning approvals,... Read more

Nikon Introduces New DS-Fi3 Microscopy Camera and DS-L4 Tablet Interface

MELVILLE, N.Y., Sept. 12, 2016 (GLOBE NEWSWIRE) — Nikon Instruments Inc. today unveiled its latest duo for capturing, viewing and replaying high-resolution imaging through the microscope. The DS-Fi3 camera for microscopy features a 5.9 megapixel CMOS image sensor with greatly improved sensitivity and low-noise electronics, while the new DS-L4 tablet interface captures and records images... Read more

Danaher To Present At Morgan Stanley Laguna Conference

WASHINGTON, Sept. 8, 2016 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Morgan Stanley Laguna Conference in Dana Point, California on Thursday, September 15, 2016 at 9:20 a.m. PT. The audio will be simultaneously webcast and the presentation will be archived... Read more

Collected application know-how for pharmaceutical analysis

Metrohm is pleased to present «Pharmaceutical analysis», a dedicated online resource providing an overview of the most important methods and applications for the determination of active ingredients, excipients, and impurities in pharmaceuticals. «Pharmaceutical analysis» draws on Metrohm’s comprehensive expertise in chemical analysis for the quality control of pharmaceuticals. Using the U.S. Pharmacopeia as a reference,... Read more

Danaher To Acquire Cepheid For $53.00 Per Share, Or Approximately $4 Billion

WASHINGTON, Sept. 6, 2016 /PRNewswire/ — Danaher Corporation (NYSE:DHR) (“Danaher” or the “Company”) announced today that it has entered into a definitive merger agreement with Cepheid (NASDAQ:CPHD) pursuant to which Danaher will acquire all of the outstanding shares of Cepheid for $53.00 per share in cash, or a total enterprise value of approximately $4 billion... Read more

New video: The Facts about Beam Delivery with Optical Fibers

September 2016 WITec applications director Dr Tom Dieing answers the questions about optical fiber beam delivery and explains the method in a comprehensible way. How does beam delivery via optical fibers work? Which advantages does the technology provide for Raman measurements? Find the answers in the latest WITec video: https://www.youtube.com/watch?v=W5pQ5rj-ODk Read more

Cynata and FUJIFILM Sign Non-binding Development and Commercialisation Term Sheet

Order Contact Careers Account Log In/Register Why CDI Partners & Providers Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services iCell Products iCell Cardiomyocytes iCell Cardiomyocytes2 iCell Cardiac Progenitor Cells iCell Neurons iCell Astrocytes iCell DopaNeurons iCell GlutaNeurons iCell Hepatocytes 2.0 iCell Hepatoblasts iCell Skeletal Myoblasts iCell Endothelial Cells... Read more

Cellular Dynamics to Realign Business Units to Better Serve Therapeutic and Life Science Customers

MADISON, WIS, September 1, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced that effective September 1, 2016 the company operations will be divided into two equally important business units. Emile Nuwaysir, PhD, President and Chief Operating Officer of CDI, will lead the Therapeutics Business Unit. The Life Science business unit will be led by... Read more